Trials / Completed
CompletedNCT00621790
Fenoldopam and Acute Renal Failure
Efficacy of Fenoldopam in Reducing the Need for Renal Replacement Therapy After Cardiac Surgery. A Randomized Controlled Study.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 667 (actual)
- Sponsor
- Università Vita-Salute San Raffaele · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Patients undergoing cardiac surgery could develop postoperative acute renal failure requiring renal replacement therapy. Fenoldopam, already used for patients with hypertensive emergencies, could improve renal function in critically ill patients with or at risk for acute renal failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fenoldopam | fenoldopam 0.1 ug/kg/min (from 0.025 to 0.3 ug/kg/min)for up to 4 days |
| DRUG | placebo | placebo |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2008-02-22
- Last updated
- 2015-10-14
Locations
19 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00621790. Inclusion in this directory is not an endorsement.